Showing results (161-170 of 2,811) with videos related to
Sort By:
Pageof 282
Diabetes Technology & Therapeutics|March 18, 2025
Automated Insulin Delivery Versus Standard of Care in the Management of People Living with Type 1 Diabetes and HbA1c <8%: A Cost-Utility Analysis in The NetherlandsErik H Serné, Maria Ida Buompensiere, Simona de Portu, et al.Diabetes Technology & Therapeutics|September 27, 2003
Continuous glucose monitoring with glucose sensors: calibration and assessment criteriaVolker Lodwig, Lutz Heinemann, Diabetes Technology & Therapeutics|September 27, 2003
Patient confidentiality, data security, and provider liabilities in diabetes managementA Michael Albisser, Jeremy B Albisser, Louise ParkerDiabetes Technology & Therapeutics|May 9, 2013
Accuracy and reliability of continuous glucose monitoring systems: a head-to-head comparisonYoeri M Luijf, Julia K Mader, Werner Doll, et al.Diabetes Technology & Therapeutics|April 13, 2013
Hypoglycemia observed during continuous glucose monitoring in patients with type 2 diabetes mellitus treated by subcutaneous insulin injectionHiroyuki Ito, Mariko Abe, Masahiro Shinozaki, et al.Diabetes Technology & Therapeutics|February 19, 2013
Assessing the quality of publications evaluating the accuracy of blood glucose monitoring systemsGary H ThorpeDiabetes Technology & Therapeutics|July 13, 2013
Psychological insulin resistance in type 2 diabetes patients regarding oral antidiabetes treatment, subcutaneous insulin injections, or inhaled insulinFrank Petrak, Stephan Herpertz, Elmar Stridde, et al.Diabetes Technology & Therapeutics|July 20, 2013
Continuous glucose monitoring pilot in low-income type 1 diabetes patientsPaola A Sequeira, Lucy Montoya, Valerie Ruelas, et al.Diabetes Technology & Therapeutics|July 20, 2013
In silico design of optimal ratio for co-administration of pramlintide and insulin in type 1 diabetesFrancesco Micheletto, Chiara Dalla Man, Orville Kolterman, et al.Diabetes Technology & Therapeutics|July 23, 2013
Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetesMaria H Lin, Crystal G Connor, Katrina J Ruedy, et al.Pageof 282